Butterfly Network (BFLY) Income from Continuing Operations (2020 - 2026)
Butterfly Network's (BFLY) quarterly Income from Continuing Operations came in at 12677000.0 in Q1 2026, up 9.24% year-on-year from 11605142.49 in Q1 2025, and up 17.1% quarter-over-quarter from 15292000.0 in Q4 2025.
Butterfly Network (BFLY) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Butterfly Network has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 12677000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 12677000.0, up 9.24% year-over-year; the trailing twelve-month figure through Mar 2026 was 75774000.0 (down 17.12% YoY), and the FY2025 annual result was 77064000.0, down 6.3% from the prior year.
- Income from Continuing Operations came in at 12677000.0 for Q1 2026 at Butterfly Network, up from 15292000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12677000.0 in Q1 2026 to a low of 54742000.0 in Q3 2022.
- The 5-year median for Income from Continuing Operations is 27368000.0 (2023), against an average of 27332823.53.
- Across the five-year window, Income from Continuing Operations tumbled 6345.94% in 2022 and surged 58.97% in 2024, its largest moves.
- Butterfly Network's Income from Continuing Operations stood at 33703000.0 in 2022, then slumped by 30.91% to 44121000.0 in 2023, then soared by 58.97% to 18103000.0 in 2024, then climbed by 15.53% to 15292000.0 in 2025, then rose by 17.1% to 12677000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 12677000.0 (Q1 2026), 15292000.0 (Q4 2025), and 33971000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Butterfly Network | 2.29 Bn | 2.15 Bn | 18.29 Mn | -12.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.68 Mn |
| Dec 31, 2025 | -15.29 Mn |
| Sep 30, 2025 | -33.97 Mn |
| Jun 30, 2025 | -13.83 Mn |
| Mar 31, 2025 | -13.97 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | -16.92 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -21.76 Mn |
| Dec 31, 2023 | -44.12 Mn |
| Sep 30, 2023 | -27.37 Mn |
| Jun 30, 2023 | -28.67 Mn |
| Mar 31, 2023 | -33.54 Mn |
| Dec 31, 2022 | -33.70 Mn |
| Sep 30, 2022 | -54.74 Mn |
| Jun 30, 2022 | -35.80 Mn |
| Mar 31, 2022 | -44.48 Mn |
| Dec 31, 2021 | -15.63 Mn |
| Sep 30, 2021 | -13.56 Mn |
| Jun 30, 2021 | -2.94 Mn |